Non-infectious Uveitis Clinical Trial
Official title:
Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS
prospective, cohort, longitudinal, multicenter, non-randomized study of patients with non-infectious posterior segment uveitis or panuveitis, with a group of control patients (scheduled for cataract or vitreoretinal surgery) and constitution of biological collection.
Description of the clinical characteristics and evolution in a large cohort of patients with non-infectious uveitis, allowing to identify prognostic or predictive factors of response after treatment of these different forms of non-infectious uveitis of the posterior segment or panuveitis (factors that are currently not well known). Uveitis patients: - Blood sample (20ml): Additional 20 ml blood sample during the first visit and potentially during follow-up (if necessary) for the purpose of the biological collection; - Ocular sample (aqueous humor, vitreous): if required by the clinical context for the needs of the biological collection; - Specific imaging: adaptive optics or Doppler holography, these procedures will be indicated on a case-by-case basis, at the investigator's discretion, and concern only patients with inflammatory vascular damage (5 to 10% of patients in the uveitis cohort); - Quality of Life NEI-VFQ 25: provided at the inclusion visit and at follow-up visits M3-V2, M12-V5 and M24-V7. Control patients: - Blood sample (20ml): Additional 20 ml blood sample during the inclusion visit at the time of the surgical scheduled procedure for the needs of the biological collection; - Ocular sample (aqueous humor, vitreous): considered as surgical waste, the tissue residues will be collected during the scheduled surgical procedure for cataract or vitreoretinal surgery for the needs of the biological collection; ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00646425 -
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
|
Phase 2 | |
| Terminated |
NCT00456482 -
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant
|
Phase 2/Phase 3 | |
| Recruiting |
NCT00720928 -
Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
|
Phase 4 | |
| Completed |
NCT04018599 -
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
|
Phase 1 | |
| Terminated |
NCT02951975 -
Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
|
||
| Active, not recruiting |
NCT03634475 -
A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis
|
Phase 1/Phase 2 | |
| Completed |
NCT04207983 -
A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)
|
Phase 2 | |
| Completed |
NCT02748512 -
Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis
|
Phase 3 | |
| Recruiting |
NCT02706704 -
Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
|
Phase 2 | |
| Terminated |
NCT01032915 -
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
|
Phase 3 | |
| Not yet recruiting |
NCT04105452 -
Study to Evaluate PL8177 in Subjects With Non Infectious Uveitis (NIU)
|
Phase 2 | |
| Terminated |
NCT01090310 -
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
|
Phase 3 | |
| Completed |
NCT01694186 -
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
|
Phase 3 | |
| Completed |
NCT03308045 -
Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis
|
Phase 1/Phase 2 | |
| Completed |
NCT00468871 -
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
|
Phase 2/Phase 3 |